Astria Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Astria Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Astria Therapeutics Inc
Rating: 1.70058325
Author: Trendlyne DVM scores

about

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of pla...

7.43 -0.09 (-1.20%)

42.31% Fall from 52W High

409.6K

XNAS Volume

XNAS 08 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

8.3 / 100

Technically Neutral

59.7 / 100

No estimates available

Astria Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Astria Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of pla...

42.31% Fall from 52W High

SWOT Analysis

Astria Therapeutics Inc Live Price Chart